Jason Kolbert analyst DAWSON JAMES

Currently out of the existing stock ratings of Jason Kolbert, 121 are a BUY (88.32%), 14 are a HOLD (10.22%), 2 are a SELL (1.46%).

Jason Kolbert

Work Performance Price Targets & Ratings Chart

Analyst Jason Kolbert works at DAWSON JAMES with a stock forecast success ratio of 51.32% fulfilled within 271.85 days on average.

Jason Kolbert’s has documented 212 price targets and ratings displayed on 36 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CTSO, Cytosorbents Crp at 28-Dec-2023.

Wall Street Analyst Jason Kolbert

Analyst best performing recommendations are on PSTI (PLURISTEM).
The best stock recommendation documented was for PSTI (PLURISTEM) at 2/10/2020. The price target of $12 was fulfilled within 74 days with a profit of $8.38 (231.49%) receiving and performance score of 31.28.

Average potential price target upside

ADMP Adamis Pharma AEZS Aeterna Zentaris ATHX Athersys BCLI Brainstorm Cell Therapeutics BLRX BioLineRx Ltd CTXR Citius Pharmaceuticals FBIO Fortress Biotech GILD Gilead Sciences GLMD Galmed Pharmaceuticals Ltd INO Inovio Pharmaceuticals ISR IsoRay MESO Mesoblast Ltd MNKD MannKind Corp NTEC Intec Pharma Ltd OMER Omeros PSTI Pluristem SRNE Sorrento Therape ACHN Achillion Pharmaceuticals CLBS Caladrius Biosciences TEVA Teva Pharma Industries Ltd ADR VRTX Vertex Pharmaceuticals AVXL Anavex Life Sciences Corp PSTV Plus Therapeutics PRPH ProPhase Labs BCDA Biocardia  ADMA ADMA Biologics BGNE BeiGene Ltd CFRX ContraFect Corp CHEK Check Cap Ltd SNGX Soligenix CANF Can Fite Biopharma Ltd ADR ONCS OncoSec Medical DYAI Dyadic International ABUS Arbutus Biopharma Corp CHRS Coherus BioSciences CTSO Cytosorbents Crp

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

4 years 4 months 18 days ago

0/1 (0%)

$1.7 (32.08%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Jason Kolbert is most bullish on?

Potential upside of $2.99 has been obtained for CTSO (CYTOSORBENTS CRP)

Which stock is Jason Kolbert is most reserved on?

Potential downside of -$0 has been obtained for CHRS (COHERUS BIOSCIENCES)

What Year was the first public recommendation made by Jason Kolbert?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?